COMMUNIQUÉS West-GlobeNewswire

Gordon Schanzlin New Vision Institute Becomes First U.S. Clinic to Use Alcon’s Breakthrough Unity Phaco System
25/06/2025
Dr. Echegoyen Participated in Clinical Trials for the First Major Phacoemulsification Advancement in Over 15 Years San Diego, CA, June 25, 2025 (GLOBE NEWSWIRE) -- Gordon Schanzlin New Vision Institute is proud to [...]
Safe Legal Steroid Alternatives New Formulation by CrazyBulk: Closest Supplements to Steroids Legally Available In USA
25/06/2025
New York City, June 25, 2025 (GLOBE NEWSWIRE) -- In a significant step forward for the fitness and bodybuilding community, CrazyBulk, a global leader in advanced sports nutrition, is proud to announce the official [...]
Ernst & Young Names USOSM’s Richard Hall an Entrepreneur Of The Year 2025 Southwest Award Winner
25/06/2025
IRVING, Texas, June 25, 2025 (GLOBE NEWSWIRE) -- Ernst & Young LLP (EY US) has announced the winners of its prestigious Entrepreneur Of The Year 2025 Southwest Award, honoring visionary leaders of high-growth [...]
Disclosure of share transfer from Inven2 AS
25/06/2025
Issuer: Zelluna ASA ISIN: NO0013524942 Date of transaction: 25 June 2025 Inven2 AS, a major shareholder in Zelluna ASA, has transferred a total of 120,796 shares in Zelluna ASA to two inventors, in accordance with a pre [...]
OPKO Health to Participate in the 3rd Annual Piper Sandler Virtual Obesity Symposium
25/06/2025
MIAMI, June 25, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (Nasdaq: OPK) today announced its participation in the 3 rd Annual Piper Sandler Obesity Symposium being held virtually on June 26, 2025. Management will be [...]
Dr. Anosh Ahmed Announces Major Expansion of COVID Testing Contracts Across U.S. and International Markets
25/06/2025
Dr. Anosh Ahmed expands U.S. and international COVID testing contracts with focus on compliance, fraud prevention, and trusted public health services CHICAGO, June 25, 2025 (GLOBE NEWSWIRE) -- Dr. Anosh Ahmed announces [...]
Valneva annonce l’approbation des résolutions présentées à son Assemblée Générale annuelle et confirme ses perspectives financières 2025
25/06/2025
Saint-Herblain (France), le 25 juin 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), société spécialisée dans les vaccins, a annoncé aujourd'hui que toutes les résolutions recommandées par son conseil d’ [...]
Valneva Announces Successful Outcome of its Annual General Meeting, Confirms FY 2025 guidance
25/06/2025
Saint-Herblain (France), June 25, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that all the resolutions recommended by the Board of Directors were approved by the [...]
Gold H2 Delivers First Successful Subsurface Bio-Stimulated Hydrogen Production Field Trial
25/06/2025
Breakthrough demonstration in California oilfield validates a new era of clean hydrogen enabled by biotechnology and advanced oilfield services provided by ChampionX LLC HOUSTON, June 25, 2025 (GLOBE NEWSWIRE) -- Gold H [...]
Plus Therapeutics Announces FDA Clearance of its Investigational New Drug Application using REYOBIQTM for the Treatment of Childhood Brain Cancer
25/06/2025
Phase 1/2a clinical trial currently supported by a $3.0 million grant from the U.S. Department of Defense Trial will enroll children with high grade glioma and ependymoma HOUSTON, June 25, 2025 (GLOBE NEWSWIRE) -- Plus [...]
Arbutus Reacquires Greater China Rights to Imdusiran and Announces Scientific Advisory Board with Late-Stage Clinical Focus
25/06/2025
Qilu Pharmaceutical and Arbutus mutually agree to conclude strategic partnership for imdusiran in Greater China Drs. Jordan Feld, Ed Gane, Anna Lok, Mark Sulkowski and Man-Fung Yuen join Arbutus Scientific Advisory [...]
Verano Unveils Bodega-Style Dispensary Experience at Zen Leaf Cave Creek in Phoenix
25/06/2025
Flipping the script on the traditional dispensary format, the new bodega-style shopping experience offers customers the freedom to browse and select their favorite items directly from shelves featuring one of the [...]
Cognition Therapeutics Provides Regulatory Update on Zervimesine (CT1812) in Alzheimer’s Disease and Dementia with Lewy Bodies (DLB)
25/06/2025
- End-of-Phase 2 Meeting with FDA for Mild-to-Moderate Alzheimer’s Disease Scheduled - - Applications for IND and Breakthrough Status Filed for Dementia with Lewy Bodies - PURCHASE, N.Y., June 25, 2025 (GLOBE NEWSWIRE [...]
Biogen to Advance Investigational Spinal Muscular Atrophy Asset to Registrational Studies Based on Positive Interim Phase 1 Results
25/06/2025
Salanersen (BIIB115/ION306) is a novel antisense oligonucleotide (ASO) with the potential to achieve high efficacy and once yearly dosing in spinal muscular atrophy (SMA) Interim Phase 1 data show children with SMA [...]
Clearmind Medicine Enrolls First Patient in its Clinical Trial for Alcoholism Treatment
25/06/2025
CMND-100 has the potential to provide an innovative and advanced treatment option for hundreds of millions of people around the world afflicted with Alcohol Use Disorder Vancouver, Canada, June 25, 2025 (GLOBE NEWSWIRE [...]
ZyVersa Therapeutics Announces Share Purchase Agreement for up to $10 Million in Partnership with Williamsburg Venture Holdings to Fund Clinical Development of Cholesterol Efflux Mediator™ VAR 200
25/06/2025
WESTON, Fla., June 25, 2025 (GLOBE NEWSWIRE) -- ZyVersa Therapeutics, Inc. (Nasdaq: ZVSA; “ZyVersa”), a clinical stage specialty biopharmaceutical company developing first-in-class drugs for treatment of patients with [...]
ImmuCell Embarks on CEO Succession Planning Process
25/06/2025
PORTLAND, Maine, June 25, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and [...]
HealthLynked Partners with Endlink to Accelerate EMR and Hospital System Integration
25/06/2025
Strategic collaboration expands HealthLynked's focus on interoperability and digital transformation in hospital systems and EMRs NAPLES, Fla., June 25, 2025 (GLOBE NEWSWIRE) -- via IBN -- HealthLynked Corp. ( OTCQB: [...]
Gero Launches ProtoBind-Diff, a Structure-Free AI Foundation Model for Targeted Small Molecule Discovery
25/06/2025
ProtoBind-Diff generates drug-like molecules for specific protein targets using only their amino acid sequences—no 3D structures required. The model performs competitively with leading structure-based tools in [...]

Pages